SeouLinBioscienceCO.,LTD. Logo

SeouLinBioscienceCO.,LTD.

A solutions provider for life sciences, supplying research reagents and equipment.

038070 | KO

Overview

Corporate Details

ISIN(s):
KR7038070009
LEI:
Country:
South Korea
Address:
경기도 성남시 분당구 삼평동 694-1 코리아바이오파크(KOREA BIO PARK) A동 4층, 성남시
Website:
N/A

Description

SeouLin Bioscience is a total solutions provider for the life sciences and healthcare sectors, specializing in bio-research and production. Established in 1984, the company supplies a comprehensive range of research reagents, laboratory equipment, and materials. It also develops and manufactures specialized products, including Hypochlorous Acid (HOCl) sterilization water generators, DNA chip scanners, and diagnostic DNA kits. The company's research and development activities focus on creating novel diagnostic solutions, such as field kits for detecting marine viruses and pathogens related to food safety. SeouLin Bioscience aims to deliver integrated solutions that support scientific discovery and bioproduction processes.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Select rows to enable
Date Filing Language Type / Size Actions
2024-11-25 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean HTML 12.4 KB
2024-11-13 00:00
분기보고서 (2024.09)
Korean HTML 1.5 MB
2024-11-07 00:00
신탁계약에의한취득상황보고서
Korean HTML 31.5 KB
2024-08-26 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean HTML 11.9 KB
2024-08-14 00:00
반기보고서 (2024.06)
Korean HTML 1.4 MB
2024-08-07 00:00
주요사항보고서(자기주식취득신탁계약체결결정)
Korean HTML 27.0 KB
2024-08-07 00:00
[기재정정]주요사항보고서(자기주식취득신탁계약체결결정)
Korean HTML 28.7 KB
2024-07-24 00:00
전환사채(해외전환사채포함)발행후만기전사채취득
Korean HTML 11.5 KB
2024-05-14 00:00
분기보고서 (2024.03)
Korean HTML 1.4 MB
2024-04-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 21.0 KB
2024-04-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 20.9 KB
2024-04-03 00:00
임원ㆍ주요주주특정증권등소유상황보고서
Korean HTML 20.9 KB
2024-03-28 00:00
정기주주총회결과
Korean HTML 24.7 KB
2024-03-28 00:00
[기재정정]정기주주총회결과
Korean HTML 27.9 KB
2024-03-28 00:00
전환가액의조정
Korean HTML 13.0 KB

Automate Your Workflow. Get a real-time feed of all SeouLinBioscienceCO.,LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for SeouLinBioscienceCO.,LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for SeouLinBioscienceCO.,LTD. via our API.

Get Historical Data →

Peer Companies

1NKEMIA Logo
Biotechnology company providing R&D and services for the life sciences sector.
Spain
IKM
2cureX AB Logo
Develops an IVD test using 3D tumoroids to predict patient response to cancer drugs.
Sweden
2CUREX
Abera Bioscience AB Logo
Develops mucosal vaccines using a proprietary Outer Membrane Vesicle (OMV) platform.
Sweden
ABERA
Clinical-stage biopharma developing therapeutics for oncology and viral diseases.
South Korea
203400
ABL Bio Inc. Logo
Develops bispecific antibody therapeutics for oncology and neurodegenerative diseases.
South Korea
298380
Abpro Holdings, Inc. Logo
Clinical-stage biotech developing antibody therapeutics for oncology and ophthalmology.
United States of America
ABP
Absci Corp Logo
A generative AI drug creation company developing biologic medicines.
United States of America
ABSI
Achiko AG Logo
A digital services platform for cross-border business compliance and engagement.
Switzerland
ACHI
Active Biotech Logo
Biotechnology company developing drugs for oncology and inflammatory eye disorders.
Sweden
ACTI
Adagene Inc. Logo
Clinical-stage biotech developing antibody-based immunotherapies for oncology.
United States of America
ADAG

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.